IGF1 and Parkinson disease: As Table 3 depicts, IGF-1 levels in almost all PD cohorts are higher in both sera and cerebrospinal fluid of these patients, particularly at the symptom’s onset (UPDRS-III) and then equals out as the disease progresses.